INVA
Innoviva IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.66B
P/E Ratio
3.59
EPS
$6.26
Beta
0.38
52W High
$25.14
52W Low
$16.52
50-Day MA
$22.92
200-Day MA
$20.86
Dividend Yield
—
Profit Margin
119.90%
Forward P/E
11.60
PEG Ratio
0.33
About Innoviva Inc
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
Fundamentals
| Revenue (TTM) | $420.69M |
| Gross Profit (TTM) | $311.74M |
| EBITDA | $192.70M |
| Operating Margin | 40.10% |
| Return on Equity | 50.70% |
| Return on Assets | 6.72% |
| Revenue/Share (TTM) | $5.99 |
| Book Value | $18.18 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | 3.94 |
| EV/Revenue | 3.126 |
| EV/EBITDA | 2.04 |
| Quarterly Earnings Growth (YoY) | 590.00% |
| Quarterly Revenue Growth (YoY) | 10.60% |
| Shares Outstanding | $73.81M |
| Float | $69.07M |
| % Insiders | 0.99% |
| % Institutions | 107.88% |
Historical Volatility
HV 10-Day
29.47%
HV 20-Day
24.52%
HV 30-Day
23.04%
HV 60-Day
23.14%
HV Rank
39.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($35.50 target)
4
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026